Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

iBio (IBIO) Equity Average (2016 - 2025)

iBio (IBIO) has disclosed Equity Average for 15 consecutive years, with $56.3 million as the latest value for Q4 2025.

  • On a quarterly basis, Equity Average rose 255.77% to $56.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $56.3 million, a 255.77% increase, with the full-year FY2025 number at $18.1 million, down 1.36% from a year prior.
  • Equity Average was $56.3 million for Q4 2025 at iBio, up from $35.5 million in the prior quarter.
  • In the past five years, Equity Average ranged from a high of $106.7 million in Q2 2021 to a low of $11.2 million in Q4 2023.
  • A 5-year average of $45.6 million and a median of $28.3 million in 2022 define the central range for Equity Average.
  • Peak YoY movement for Equity Average: soared 6072.56% in 2021, then tumbled 78.7% in 2023.
  • iBio's Equity Average stood at $95.6 million in 2021, then crashed by 64.84% to $33.6 million in 2022, then tumbled by 66.65% to $11.2 million in 2023, then skyrocketed by 41.25% to $15.8 million in 2024, then soared by 255.77% to $56.3 million in 2025.
  • Per Business Quant, the three most recent readings for IBIO's Equity Average are $56.3 million (Q4 2025), $35.5 million (Q3 2025), and $13.1 million (Q2 2025).